<?xml version="1.0" encoding="UTF-8"?>
<GaPExchange xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:noNamespaceSchemaLocation="./dbGaPEx2.1.5.xsd">

<MetaVariables>
	<Submitter/>
	<Method/>
</MetaVariables>
<MetaLinks/>

<Projects>
	<Project/>
</Projects>

<Studies>

<Study source="dbGaP" accession="phs000953.v1.p1" parentStudy="phs000953.v1.p1" createDate="2015-07-10" modDate="2015-07-24">

<Configuration>
	<Data_Provider><![CDATA[
		<table border="1">
		<tr><th>Title</th><th>Name</th><th>Institute</th></tr>
		<tr><td>Principal Investigator</td><td>Agnieszka Witkiewicz</td><td>University of Texas Southwestern Medical Center, Dallas, TX, USA</td></tr>
		<tr><td>Co-Investigator</td><td>Erik Knudsen</td><td>University of Texas Southwestern Medical Center, Dallas, TX, USA</td></tr>
		</table>
	]]></Data_Provider>
	<StudyNameEntrez>Microdissected Pancreatic Cancer Whole Exome Sequencing</StudyNameEntrez>
	<StudyNameReportPage>Microdissected Pancreatic Cancer Whole Exome Sequencing</StudyNameReportPage>
	<StudyTypes>
		<StudyType>Longitudinal Cohort</StudyType>
	</StudyTypes>
	<Description><![CDATA[
<p>109 micro-dissected pancreatic cancer cases and normal control tissue were subjected to whole-exome sequencing. Microdissection enriches tumor cellularity and enhances mutation calling.</p>]]>
	</Description>
	<StudyInEx><![CDATA[
<p>Inclusion: Diagnosis of pancreatic cancer with sufficient available tumor tissue and normal control.</p>]]>
	</StudyInEx>
	<StudyProjects>
		<Project/>
	</StudyProjects>
	<Publications>
		<Publication>
			<Pubmed pmid="25855536"/>
		</Publication>
	</Publications>
	<Diseases>
		<Disease vocab_source="MESH" vocab_term="Pancreatic Neoplasms"/>
	</Diseases>
	<Attributions>
		<Header title="Principal Investigator">
			<AttName>Agnieszka Witkiewicz</AttName>
			<Institution>University of Texas Southwestern Medical Center, Dallas, TX, USA</Institution>
		</Header>
		<Header title="Co-Investigator">
			<AttName>Erik Knudsen</AttName>
			<Institution>University of Texas Southwestern Medical Center, Dallas, TX, USA</Institution>
		</Header>
	</Attributions>
	<DisplayPublicSummary>yes</DisplayPublicSummary>
	<ConsentGroups>
		<ConsentGroup groupNum="1" shortName="DS-PACA-IRB-NPU-MDS" longName="Disease-Specific (Pancreatic Cancer, IRB, NPU, MDS)"/>
	</ConsentGroups>
</Configuration>

  <AuthorizedAccess>
    <DacInfo ssDacId="0">
      <DacName>NCI</DacName>
      <DacFullName>NCI</DacFullName>
      <DacEmail>0</DacEmail>
      <DacPhone></DacPhone>
      <DacUrl></DacUrl>
    </DacInfo>
    <Policy Policy_ID="phs000953.v1.p1_policy" ref_ssDacId="0">
      <DisplayResearchStatement>yes</DisplayResearchStatement>
      <DisplayPublicSummary>yes</DisplayPublicSummary>
      <EmbargoLength>0</EmbargoLength>
      <YearsUntilRenewal>1</YearsUntilRenewal>
      <WeeksCancelRequest>8</WeeksCancelRequest>
      <PdfSupplementReqired>yes</PdfSupplementReqired>
      <AcknowledgementText>
        <para>
          http://dbgap.ncbi.nlm.nih.gov/aa/wga.cgi?page=DUC&amp;view_pdf&amp;stacc=phs000953.v1.p1
        </para>
      </AcknowledgementText>
      <DocumentSet>
        <DataUseCertificate Label="Data Use Certificate" FilePath="https://dbgap.ncbi.nlm.nih.gov/aa/wga.cgi?page=DUC&amp;view_pdf&amp;stacc=phs000953.v1.p1" FileName=""/>
      </DocumentSet>
    </Policy>
    <ConsentGroups>
      <ParticipantSet groupNum-REF="1">
        <ConsentName>Disease-Specific (Pancreatic Cancer, IRB, NPU, MDS)</ConsentName>
        <ConsentAbbrev>DS-PACA-IRB-NPU-MDS</ConsentAbbrev>
        <UseLimitation>Use of the data must be related to Pancreatic Cancer.
Requestor must provide documentation of local IRB approval.
Use of the data is limited to not-for-profit organizations.
Use of the data includes methods development research (e.g., development of software or algorithms).</UseLimitation>
        <IrbRequired>Yes</IrbRequired>
      </ParticipantSet>
    </ConsentGroups>
  </AuthorizedAccess>


</Study>

</Studies>

</GaPExchange>
